Hospital
Ihc Health Services INC
Ihc Health Services INC was paid $11.66M by Medicaid between Jan 2018 and Oct 2023, across 110 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 79% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES INC
SANDY, UT 84094
SANDY, UT 84094
33aNPI1962412486assigned 08/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.66M
24GClaims154,653
24DCodes billed110
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other General Acute Care Hospital providers in Utah
Rank by total paid#10 of 26
Median peer was paid$6.14M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,414 | $1.33M | |
| 2019 | 23,265 | $1.42M | |
| 2020 | 30,490 | $2.29M | |
| 2021 | 41,323 | $3.45M | |
| 2022 | 36,609 | $3.06M | |
| 2023 | 1,552 | $109K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 79% | 22,997 | 10,843 | $9.23M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 10,110 | 8,239 | $345K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 5,785 | 4,893 | $262K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.0% | 5,762 | 5,118 | $236K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.8% | 1,633 | 1,526 | $204K |
| 80050 | General health panel | <1% | 1,299 | 1,174 | $115K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | <1% | 7,257 | 6,335 | $115K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 781 | 662 | $107K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,583 | 1,444 | $79K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,084 | 3,435 | $75K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,271 | 975 | $71K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 4,599 | 4,022 | $59K |
98 more codes
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,058 | $54K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,326 | $39K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,532 | $39K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,547 | $34K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,284 | $33K |
| 81001 | <1% | 5,352 | $32K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,692 | $31K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,230 | $29K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,896 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,397 | $26K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 674 | $23K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,129 | $23K |
| 80053 | Comprehensive metabolic panel | <1% | 8,732 | $22K |
| 85027 | <1% | 726 | $21K | |
| 82330 | <1% | 1,188 | $20K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,961 | $20K |
| 84702 | <1% | 2,918 | $19K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 598 | $18K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,583 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,367 | $17K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 513 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 218 | $15K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 296 | $15K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 371 | $14K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,506 | $13K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 848 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,723 | $11K |
| 96376 | <1% | 960 | $11K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,476 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,784 | $9K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 401 | $8K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,959 | $8K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 789 | $7K |
| 83690 | <1% | 3,407 | $6K | |
| 84484 | <1% | 2,329 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,788 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 749 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 67 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 167 | $4K |
| 86901 | <1% | 41 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 475 | $3K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 646 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 859 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,651 | $2K |
| 87186 | <1% | 249 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 58 | $2K |
| 83605 | <1% | 2,443 | $2K | |
| 85610 | <1% | 598 | $2K | |
| 81025 | <1% | 44 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 120 | $1K |
| 97161 | <1% | 14 | $1K | |
| 93971 | <1% | 41 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 372 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 298 | $987.95 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 29 | $758.76 |
| 85379 | <1% | 850 | $703.82 | |
| 86140 | <1% | 395 | $642.86 | |
| 73610 | <1% | 27 | $510.65 | |
| 73630 | <1% | 13 | $462.71 | |
| 76770 | <1% | 15 | $401.78 | |
| 82247 | <1% | 50 | $319.10 | |
| 87088 | <1% | 171 | $268.94 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 47 | $253.12 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 19 | $238.87 |
| 73562 | <1% | 16 | $218.52 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 35 | $218.23 |
| 76801 | <1% | 14 | $205.34 | |
| 82803 | <1% | 270 | $158.56 | |
| 83735 | <1% | 488 | $121.90 | |
| 90715 | <1% | 13 | $80.00 | |
| 83880 | <1% | 52 | $57.37 | |
| J3490 | Unclassified drugs | <1% | 14 | $55.36 |
| 82248 | <1% | 20 | $50.18 | |
| 86850 | <1% | 12 | $46.86 | |
| 84439 | <1% | 28 | $36.88 | |
| 80061 | Lipid panel | <1% | 13 | $33.26 |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 171 | $26.87 |
| 82728 | <1% | 48 | $23.02 | |
| 84703 | <1% | 527 | $18.94 | |
| 87040 | <1% | 131 | $13.90 | |
| 85651 | 0% | 104 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 16 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 61 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 26 | $0.00 |
| 87070 | 0% | 16 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 12 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 12 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 83 | $0.00 |
| 84478 | 0% | 15 | $0.00 | |
| 90686 | 0% | 23 | $0.00 | |
| 88304 | 0% | 13 | $0.00 | |
| 83615 | 0% | 16 | $0.00 | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 0% | 18 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 18 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 45 | $0.00 |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 25 | $0.00 |
| 86900 | 0% | 12 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 59 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DENIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $68.77M |
| Ihc Health Services, INC. | St George, UT | $65.78M |
| Ihc Health Services INC | Ogden, UT | $54.08M |
| Ihc Health Services, INC. | Provo, UT | $44.35M |
| Ihc Health Services INC | Logan, UT | $25.34M |
| Ihc Health Services, INC. | Cedar City, UT | $20.40M |
| Ihc Health Services, INC. | Salt Lake City, UT | $19.91M |
| Ihc Health Services, INC. | American Fork, UT | $17.19M |
| Ihc Health Services INC | Riverton, UT | $15.31M |
| Ihc Health Services, INC. | Layton, UT | $11.61M |
| Ihc Health Services, INC. | Burley, ID | $5.14M |
| Ihc Health Services INC | Murray, UT | $4.64M |
| Ihc Health Services INC | St George, UT | $4.35M |
| Ihc Health Services INC | Heber City, UT | $4.31M |
| Ihc Health Services, INC. | Orem, UT | $4.18M |
| Ihc Health Services, INC. | Richfield, UT | $3.87M |
| Ihc Health Services INC | Tremonton, UT | $3.55M |
| Ihc Health Services, INC. | Spanish Fork, UT | $3.49M |
| Ihc Health Services INC | Park City, UT | $2.53M |
| Ihc Health Services, INC. | Mt Pleasant, UT | $2.34M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.